marax 20 cap
unimed - hydroxyzine hcl.,ephedrine hcl.,theophylline - cap - 10,25,130;mg - 20
marax
anhydrous theophylline 130mg, ephedrine s04 25mg, hydroxyzine dihydrochloride 10mg
marax
ephedrine sulphate hydroxyzine dihydrochloride 2.5mg, anhydrous theophylline 32.5mg
marax
hydroxyzine 25mg. theophylline 130mg
cedax
merck sharp & dohme corp.13900 north west 57th court - ceftibuten - capsules hard - 400mg
cedax
merck sharp & dohme corp.13900 north west 57th court - ceftibuten - powder for oral suspension - 36mg/ml
iberogast ibs relief oral liquid solution bottle
bayer australia ltd - matricaria chamomilla, quantity: 200 microlitre/ml (equivalent: matricaria chamomilla, qty 66.67 mg/ml; equivalent: matricaria recutita, qty 66.67 mg/ml); glycyrrhiza glabra, quantity: 100 microlitre/ml (equivalent: glycyrrhiza glabra, qty 33.33 mg/ml); chelidonium majus, quantity: 100 microlitre/ml (equivalent: chelidonium majus, qty 33.33 mg/ml); mentha x piperita, quantity: 50 microlitre/ml (equivalent: mentha x piperita, qty 16.67 mg/ml); angelica archangelica, quantity: 100 microlitre/ml (equivalent: angelica archangelica, qty 33.33 mg/ml); melissa officinalis, quantity: 100 microlitre/ml (equivalent: melissa officinalis, qty 33.33 mg/ml); iberis amara, quantity: 150 microgram/ml (equivalent: iberis amara, qty 75 mg/ml); carum carvi, quantity: 100 microlitre/ml (equivalent: carum carvi, qty 33.33 mg/ml); silybum marianum, quantity: 100 microlitre/ml (equivalent: silybum marianum, qty 33.33 mg/ml) - oral liquid, solution - excipient ingredients: purified water; ethanol - for the treatment of gastric and abdominal discomfort associated with functional and motility-conditioned gastrointestinal disturbances such as functional dyspepsia and irritable bowel syndrome.
serenace liquid haloperidol 2 mg/ml oral liquid bottle
aspen pharmacare australia pty ltd - haloperidol, quantity: 2 mg/ml - oral liquid, solution - excipient ingredients: methyl hydroxybenzoate; purified water; propyl hydroxybenzoate; lactic acid - chronic therapy: the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome. short term therapy: the treatment of acute alcoholism for the relief of delusions, hallucinations and confused states, and for the control of accompanying tremulousness and aggressive behaviour. in the treatment of intractable nausea and vomiting associated with radiation or malignancy and not responding to other therapy. neuroleptanalgesia
painstop night-time pain reliever oral liquid bottle
care pharmaceuticals pty ltd - codeine phosphate hemihydrate, quantity: 1 mg/ml; paracetamol, quantity: 24 mg/ml; promethazine hydrochloride, quantity: 1.3 mg/ml - oral liquid, solution - excipient ingredients: purified water; sodium metabisulfite; sorbitol solution (70 per cent) (non-crystallising); propylene glycol; sucrose; disodium edetate; saccharin sodium; brilliant blue fcf; amaranth; phosphoric acid; ethanol; flavour - for the temporary relief of acute moderate pain when paracetamol alone is not sufficient and sedation is considered beneficial in patients over the age of 12 years ( see also contraindications and paediatric use)
rikodeine 9.5mg/5ml oral liquid bottle
inova pharmaceuticals (australia) pty ltd - dihydrocodeine tartrate, quantity: 1.9 mg/ml - oral liquid - excipient ingredients: purified water; sucrose; citric acid; methyl hydroxybenzoate; amaranth; sorbitol; flavour - for relief of stubborn, unproductive cough.